LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
142.80
+2.80 (2.00%)
Jun 18, 2026, 4:08 PM HKT
48.66% (1Y)
| Market Cap | 10.39B |
| Revenue (ttm) | n/a |
| Net Income | -195.39M |
| EPS | -3.45 |
| Shares Out | 74.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 276,510 |
| Open | 140.00 |
| Previous Close | 140.00 |
| Day's Range | 137.00 - 142.90 |
| 52-Week Range | 96.06 - 158.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |